HCV(ELISA)

ʻO nā kumu maʻi maʻi nui o ka maʻi hepa C he ʻano maʻi maʻi a me nā maʻi subclinical asymptomatic, nā maʻi maʻi a me nā mea lawe maʻi.He 12 lā ma mua o ka hoʻomaka ʻana o ka maʻi, hiki ke lawe i ka maʻi maʻi ma mua o 12 mau makahiki.Hoʻouna ʻia ka HCV mai nā kumu koko.Ma nā ʻāina ʻē, ʻo 30-90% o ka maʻi hepa ma hope o ka hoʻololi ʻana he hepatitis C, a ma Kina, ʻo ka maʻi hepa C no ka 1/3 o ka maʻi hepatitis ma hope o ka lawe ʻana.Eia kekahi, hiki ke hoʻohana ʻia nā ʻano hana ʻē aʻe, e like me ka hoʻouna ʻana o ka makuahine i ke keiki, ka pilina ʻohana i kēlā me kēia lā a me ka hoʻouna ʻana i ka moekolohe.
Ke hoʻokomo ʻia ka plasma a i ʻole nā ​​​​huahana koko e loaʻa ana i ka HCV a i ʻole HCV-RNA, maʻamau lākou e lilo i mea maʻamau ma hope o 6-7 mau pule o ka wā incubation.ʻO nā hōʻike lapaʻau ʻo ia ka nāwaliwali maʻamau, ka ʻai ʻole o ka ʻōpū, a me ka hōʻoluʻolu ma ka ʻāpana ate.Hoʻokahi hapakolu o nā maʻi i loaʻa i ka jaundice, hoʻokiʻekiʻe ʻia ka ALT, a me ka antibody anti HCV maikaʻi.Hiki i ka 50% o nā maʻi maʻi hepatitis C ke hoʻomohala i ka maʻi hepatitis mau loa, ʻoiai kekahi mau maʻi e alakaʻi i ka cirrhosis ate a me ka maʻi hepatocellular carcinoma.ʻO ke koena hapa o nā maʻi i kaupalena ʻia a hiki ke hoʻōla maʻalahi.